Heavy metal star Ozzy Osbourne reveals the date for his final show, which will also reunite the founding members of Black ...
Ozzy Osbourne will come out of touring retirement and reunite with the full Black Sabbath lineup for the first time in 20 ...
Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...
Conductor Daniel Barenboim says he has been diagnosed with Parkinson's disease. The 82-year-old issued a statement Thursday ...
People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.
The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...
Daniel Barenboim, the eminent conductor and pianist who stepped back from engagements in recent years citing health concerns, ...
WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's ...
The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.
All aboard the "Crazy Train" — Black Sabbath will be reuniting for a performance in Ozzy Osbourne's hometown of Birmingham, U ...
We spend billions searching for the cures to chronic illnesses while neglecting research that could make the daily lives of ...
The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results